Montréal – TheNewswire - November 11, 2021 – ZeU Technologies, Inc. ZEU ZEUCF ZEU is pleased to announce that it was notified earlier today that a first online gaming company had completed production testing of one of its games developed in partnership with KamPay.
The dice game will be operated by MJ Global, owner of the PlayMoon.io website. Players will be able to play the game using KamPay token. Token transactions will be automated for payouts and fees, according to the JV agreement between the two companies, after a short live testing period following the soft launch.
Play Moon is expected to launch many new games from ZeU in the coming months. ZeU's management expects that everything will be in place to launch ZeU's "Mad Candle" game before the end of this year. The Company is also working on bet syndication and buy-outs that could be deployed later in 2022, allowing players with smaller bets to participate as a group in very large game pots.
Each game will be soft-launched to test different technologies developed by ZeU, some for which the Company has filed patent applications in different jurisdictions worldwide.
The Company expects to be able to demonstrate its peer-to-peer gaming platform that allows players and stakeholders to participate in the revenue sharing of the platform by staking gaming tokens, hence owning a share of the casino or the lottery, after a legal review is completed by its license holding partners.
_____________________________________________________________________________________
ON BEHALF OF THE BOARD OF DIRECTORS
"Frank Dumas"
Frank Dumas
President & CEO
About ZeU
ZeU is a forward-thinking Canadian technology company that has developed a state-of-the-art DLT protocol, providing the foundation for the next generation of encrypted and distributed networks. Thanks to its high level of sophistication, ZeU's technology maximizes transparency, security and scalability as well as big data management. ZeU's strategy is to monetize DLT transactions in diverse sectors such as payment, gaming, data, and healthcare.
The CSE has in no way passed upon the merits of the Transaction and has neither approved nor disapproved the contents of this press release.
Copyright (c) 2021 TheNewswire - All rights reserved.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.